Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jun 23;6(3):e00358-21. doi: 10.1128/mSphere.00358-21

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Wieneke et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

PMC Copyright notice

FIG 4 — Heatmaps of S. aureus isolates of patients 1 and 9 with inflammatory and lung function data of every visit. The heatmaps illustrate all data for 40 S. aureus isolates collected during every visit in terms of spa type (dominant spa type/related to the dominant spa type/not related), phenotype (PT) (mucoidy, hemolysis, β-toxin, SCV phenotype [all positive/negative], pigment [gray/white/yellow] as well as biofilm formation [low < 10% / high > 10% of the positive control] and nuclease activity [low < 100% / high > 100% of the positive control]). Below the heatmap, data of all visits are reported for months from first visit, exacerbation, P. aeruginosa coinfection, SDI for spa type and PTs. Data for S100A8/9, CRP, IL-6, and FEV₁%pred are given for every visit in a table and illustrated as a graph with visits of exacerbation marked with a red arrow.

FIG 4 — Heatmaps of S. aureus isolates of patients 1 and 9 with inflammatory and lung function data of every visit. The heatmaps illustrate all data for 40 S. aureus isolates collected during every visit in terms of spa type (dominant spa type/related to the dominant spa type/not related), phenotype (PT) (mucoidy, hemolysis, β-toxin, SCV phenotype [all positive/negative], pigment [gray/white/yellow] as well as biofilm formation [low < 10% / high > 10% of the positive control] and nuclease activity [low < 100% / high > 100% of the positive control]). Below the heatmap, data of all visits are reported for months from first visit, exacerbation, P. aeruginosa coinfection, SDI for spa type and PTs. Data for S100A8/9, CRP, IL-6, and FEV₁%pred are given for every visit in a table and illustrated as a graph with visits of exacerbation marked with a red arrow.